Follicular T helper (TFH) cells are a unique subset of CD4+ T cells. Their main function is to participate in the formation of germinal centres (GC) and help B cells produce antibodies for involvement in humoral immune responses. TFH cell dysregulation can cause various autoimmune diseases, such as type 1 diabetes mellitus (T1DM), systemic lupus erythaematosus (SLE) and rheumatoid arthritis. Among them, T1DM is usually accompanied by high levels of autoantibodies, such as insulin antibody (IAA) and glutamate decarboxylase 65 antibody (GAD65Ab). The production of these autoantibodies is closely related to the production and activation of TFH cells in vivo, which promotes the development of T1DM. Therefore, this review will focus on the relationship between TFH cells and T1DM and the possible mechanisms that affect the disease and summarize the current strategies for targeting TFH cells in the treatment of T1DM.
The role of follicular T helper cells in the onset and treatment of type 1 diabetes.
Xue-Yang Zou,Shuang Wang,Yi Zhang,Xiaoya Wang,Wei Yang
Published 2020 in International Immunopharmacology
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
International Immunopharmacology
- Publication date
2020-04-13
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-48 of 48 references · Page 1 of 1
CITED BY
Showing 1-7 of 7 citing papers · Page 1 of 1